The deal builds on Novonesis’ original 2013 investment in MicroBioGen and its current 23% stake in the Sydney-based firm, extending a collaboration between the two companies that spans more than a decade.
A new international milestone for the global baking industry, completing the harmonized framework for baker’s yeast quality.
The acquisition aims to accelerate Biospringer’s growth in the food ingredients market, unlocking new opportunities beyond yeast fermentation.
The project will build a large, proprietary library of wild yeast strains and aims to accelerate the discovery and commercialization of natural yeast species for a wide variety of high-value industrial applications.